HNRNPA2B1 and neoplasm: The IHC results indicated that about 67% of the tumor tissues (2 of 3) with low NUF2 expression showed negative or weak HNRNPA2B1 staining and 80% (8 of 10) of those with high NUF2 expression displayed moderate or strong HNRNPA2B1 staining (Fig. 5C).